View in EDS

Genomic landscape of multiple myeloma and its precursor conditions.

Saved in:
Bibliographic Details
Title: Genomic landscape of multiple myeloma and its precursor conditions.
Authors: Alberge JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Dutta AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Poletti A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Coorens THH; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lightbody ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Toenges R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Loinaz X; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wallin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Dunford A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Priebe O; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Dagan J; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Boehner CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Horowitz E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Su NK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Barr H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hevenor L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Towle K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Beesam R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Beckwith JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Perry J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cordas Dos Santos DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bertamini L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Greipp PT; Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA., Kübler K; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center of Functional Genomics, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Krantz Family Center for Cancer Research and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Arndt PF; Department of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany., Terragna C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Zamagni E; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Boyle EM; Department of Haematology, Cancer Institute, University College London Cancer Institute, London, UK., Yong K; Department of Haematology, Cancer Institute, University College London Cancer Institute, London, UK., Morgan G; Myeloma Research Program, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Walker BA; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA., Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Hess J; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sklavenitis-Pistofidis R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Stewart C; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Getz G; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Krantz Family Center for Cancer Research and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Department of Pathology, Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org., Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. irene_ghobrial@dfci.harvard.edu.
Source: Nature genetics [Nat Genet] 2025 Jun; Vol. 57 (6), pp. 1493-1503. Date of Electronic Publication: 2025 May 21.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40399554
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Genomic landscape of multiple myeloma and its precursor conditions.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Alberge+JB%22">Alberge JB</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dutta+AK%22">Dutta AK</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Poletti+A%22">Poletti A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Coorens+THH%22">Coorens THH</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lightbody+ED%22">Lightbody ED</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Toenges+R%22">Toenges R</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Loinaz+X%22">Loinaz X</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wallin+S%22">Wallin S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dunford+A%22">Dunford A</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Priebe+O%22">Priebe O</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dagan+J%22">Dagan J</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Boehner+CJ%22">Boehner CJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Horowitz+E%22">Horowitz E</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Su+NK%22">Su NK</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Barr+H%22">Barr H</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hevenor+L%22">Hevenor L</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Towle+K%22">Towle K</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Beesam+R%22">Beesam R</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Beckwith+JB%22">Beckwith JB</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Perry+J%22">Perry J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cordas+Dos+Santos+DM%22">Cordas Dos Santos DM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bertamini+L%22">Bertamini L</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Greipp+PT%22">Greipp PT</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Kübler+K%22">Kübler K</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center of Functional Genomics, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Krantz Family Center for Cancer Research and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Arndt+PF%22">Arndt PF</searchLink>; Department of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Terragna+C%22">Terragna C</searchLink>; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Zamagni+E%22">Zamagni E</searchLink>; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Boyle+EM%22">Boyle EM</searchLink>; Department of Haematology, Cancer Institute, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Yong+K%22">Yong K</searchLink>; Department of Haematology, Cancer Institute, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Morgan+G%22">Morgan G</searchLink>; Myeloma Research Program, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Walker+BA%22">Walker BA</searchLink>; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Dimopoulos+MA%22">Dimopoulos MA</searchLink>; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Kastritis+E%22">Kastritis E</searchLink>; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Hess+J%22">Hess J</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sklavenitis-Pistofidis+R%22">Sklavenitis-Pistofidis R</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Stewart+C%22">Stewart C</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Getz+G%22">Getz G</searchLink>; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Krantz Family Center for Cancer Research and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Department of Pathology, Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.<br /><searchLink fieldCode="AU" term="%22Ghobrial+IM%22">Ghobrial IM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. irene_ghobrial@dfci.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229216904%22">Nature genetics</searchLink> [Nat Genet] 2025 Jun; Vol. 57 (6), pp. 1493-1503. <i>Date of Electronic Publication: </i>2025 May 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Co%22">Nature Pub. Co </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9216904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-1718 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210614036%22">10614036 </searchLink><i>NLM ISO Abbreviation: </i>Nat Genet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40399554
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41588-025-02196-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1493
    Titles:
      – TitleFull: Genomic landscape of multiple myeloma and its precursor conditions.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Alberge JB
      – PersonEntity:
          Name:
            NameFull: Dutta AK
      – PersonEntity:
          Name:
            NameFull: Poletti A
      – PersonEntity:
          Name:
            NameFull: Coorens THH
      – PersonEntity:
          Name:
            NameFull: Lightbody ED
      – PersonEntity:
          Name:
            NameFull: Toenges R
      – PersonEntity:
          Name:
            NameFull: Loinaz X
      – PersonEntity:
          Name:
            NameFull: Wallin S
      – PersonEntity:
          Name:
            NameFull: Dunford A
      – PersonEntity:
          Name:
            NameFull: Priebe O
      – PersonEntity:
          Name:
            NameFull: Dagan J
      – PersonEntity:
          Name:
            NameFull: Boehner CJ
      – PersonEntity:
          Name:
            NameFull: Horowitz E
      – PersonEntity:
          Name:
            NameFull: Su NK
      – PersonEntity:
          Name:
            NameFull: Barr H
      – PersonEntity:
          Name:
            NameFull: Hevenor L
      – PersonEntity:
          Name:
            NameFull: Towle K
      – PersonEntity:
          Name:
            NameFull: Beesam R
      – PersonEntity:
          Name:
            NameFull: Beckwith JB
      – PersonEntity:
          Name:
            NameFull: Perry J
      – PersonEntity:
          Name:
            NameFull: Cordas Dos Santos DM
      – PersonEntity:
          Name:
            NameFull: Bertamini L
      – PersonEntity:
          Name:
            NameFull: Greipp PT
      – PersonEntity:
          Name:
            NameFull: Kübler K
      – PersonEntity:
          Name:
            NameFull: Arndt PF
      – PersonEntity:
          Name:
            NameFull: Terragna C
      – PersonEntity:
          Name:
            NameFull: Zamagni E
      – PersonEntity:
          Name:
            NameFull: Boyle EM
      – PersonEntity:
          Name:
            NameFull: Yong K
      – PersonEntity:
          Name:
            NameFull: Morgan G
      – PersonEntity:
          Name:
            NameFull: Walker BA
      – PersonEntity:
          Name:
            NameFull: Dimopoulos MA
      – PersonEntity:
          Name:
            NameFull: Kastritis E
      – PersonEntity:
          Name:
            NameFull: Hess J
      – PersonEntity:
          Name:
            NameFull: Sklavenitis-Pistofidis R
      – PersonEntity:
          Name:
            NameFull: Stewart C
      – PersonEntity:
          Name:
            NameFull: Getz G
      – PersonEntity:
          Name:
            NameFull: Ghobrial IM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1546-1718
          Numbering:
            – Type: volume
              Value: 57
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Nature genetics
              Type: main
ResultId 1